Serum IL-22 was elevated in 325 patients, and in these patients, the median OS was 10.71 (95% CI: [8.8, 14.85), which was shorter compared to the OS of 15.74 months (95% CI: 13.17, 17.87) in patients with low IL-22 but did not reach statistical significance ( p = 0.055) ( Table 2 ).
← all excerpts
Clinical and Prognostic Biomarker Value of Blood-Circulating Inflammatory Cytokines in Hepatocellular Carcinoma.
1
0.0550
0.0550